Differential regulation of the expression of CD95 ligand, receptor activator of nuclear factor-κB ligand (RANKL), TNF-related apoptosis-inducing ligand (TRAIL), and TNF-α during T cell activation

Journal of Immunology

Volumn 166, Issue 3, 2001, Pages 1983-1990

  Wang, R ^a   Zhang, L ^a   Zhang, X ^a   Moreno, J ^a   Luo, X ^a   Tondravi, M ^a   Shi, Y ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; DEXAMETHASONE; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN KINASE C; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANIMAL CELL; ARTICLE; CALCIUM MOBILIZATION; CALCIUM SIGNALING; CONTROLLED STUDY; GENE EXPRESSION REGULATION; IMMUNOMODULATION; MOUSE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN TRANSPORT; REGULATORY MECHANISM; T LYMPHOCYTE ACTIVATION;

EID: 0035253369     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.166.3.1983     Document Type: Article

References (75)

1. Apoptosis control by death and decoy receptors
2. A family of ligands for the TNF receptor superfamily
3. Molecular, structural, and biological characteristics of the tumor necrosis factor ligand superfamily
4. Modulation of life and death by the TNF receptor superfamily
5. TNF-related ligands and their receptors
6. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor α gene promoter
7. Cell-type-specific regulation of the human tumor necrosis factor α gene in B cells and T cells by NFATp and ATF-2/JUN
8. Role of the cyclosporin-sensitive transcription factor NFAT1 in the allergic response
9. Characterization of a new isoform of the NFAT (nuclear factor of activated T cells) gene family member NFATc
10. Calcineurin mediates human tumor necrosis factor α gene induction in stimulated T and B cells
11. Human tumor necrosis factor α gene regulation in phorbol ester stimulated T and B cell lines
12. Regulation of NF-κB activity in murine macrophages: Effect of bacterial lipopolysaccharide and phorbol ester
13. Activation of NF-κB by the Tax protein of HTLV-1
14. Relevance of the tumor necrosis factor α (TNF α)-308 promoter polymorphism in TNF α gene regulation
15. Molecular mechanisms of tumor necrosis factor α gene expression in monocytic cells via hyperglycemia-induced oxidant stress-dependent and -independent pathways
16. The regulation of the human tumor necrosis factor α promoter region in macrophage, T cell, and B cell lines
17. Protein kinase C regulates Fas (CD95/APO-1) expression
18. Regulation of cell surface expression of Fas (CD95) ligand and susceptibility to Fas (CD95)-mediated apoptosis in activation-induced T cell death involves calcineurin and protein kinase C, respectively
19. Protein kinase Cθ cooperates with calcineurin to induce Fas ligand expression during activation-induced T cell death
20. Fas and activation-induced Fas ligand mediate apoptosis of T cell hybridomas: Inhibition of Fas ligand expression by retinoic acid and glucocorticoids
21. Activation-induced cell death in murine T cell hybridomas: Differential regulation of Fas (CD95) versus Fas ligand expression by cyclosporin A and FK506
22. Regulation of CD95 (Fas) ligand expression by TCR-mediated signaling events
23. Identification of two NF-κB sites in mouse CD95 ligand (Fas ligand) promoter: Functional analysis in T cell hybridoma
24. NF-κB-dependent Fas ligand expression
25. Transcriptional regulation of the human FasL promoter-enhancer region
26. Two NFAT transcription factor binding sites participate in the regulation of CD95 (Fas) ligand expression in activated human T cells
27. RORγ t, a novel isoform of an orphan receptor, negatively regulates Fas ligand expression and IL-2 production in T cells
28. Regulation of Fas ligand expression and cell death by apoptosis-linked gene 4
29. Cyclosporin A-sensitive transcription factor Egr-3 regulates Fas ligand expression
30. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1
31. Fungal metabolite FR901228 inhibits c-Myc and Fas ligand expression
32. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function
33. Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): A mechanism by which OPG/OCIF inhibits osteoclastogenesis in vitro
34. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
35. OPG/FDCR-1, a TNF receptor family member, is expressed in lymphoid cells and is up-regulated by ligating CD40
36. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function
37. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells
38. TRANCE is a TNF family member that regulates dendritic cell and osteoclast function
39. Osteoprotegerin ligand: A common link between osteoclastogenesis, lymph node formation and lymphocyte development
40. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
41. Cell death: TRAIL and its receptors
42. To die or not to die: The quest of the TRAIL receptors
43. Murine TRAIL (TNF-related apoptosis inducing ligand) expression induced by T cell activation is blocked by rapamycin, cyclosporin A, and inhibitors of phosphatidylinositol 3-kinase, protein kinase C, and protein tyrosine kinases: Evidence for TRAIL induction via the T cell receptor signaling pathway
44. IFN-γ mediates a novel antiviral activity through dynamic modulation of TRAIL and TRAIL receptor expression
45. Type I interferons (IFNs) regulate tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression on human T cells: A novel mechanism for the antitumor effects of type I IFNs
46. Fine specificity of antigen recognition by T cell hybridoma clones specific for poly- 18: A synthetic polypeptide antigen of defined sequence and conformation
47. Inhibition of transformed T cell growth in vitro by monoclonal antibodies directed against distinct activating molecules
48. Cyclosporin A inhibits activation-induced cell death in T-cell hybridomas and thymocytes
49. Activation-induced cell death in T cell hybridomas is due to apoptosis: Morphologic aspects and DNA fragmentation
50. Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation
51. Cell-autonomous Fas (CD95)/Fas-ligand interaction mediates activation-induced apoptosis in T-cell hybridomas
52. TRAIL as an inhibitor of autoimmune inflammation and cell cycle progression
53. T cell antigen-receptor signal transduction
54. Signal transduction by lymphocyte antigen receptors
55. Early activation defects in T lymphocytes from aged mice
56. Regulation of T cell apoptosis via T cell receptors and steroid receptors
57. Biology of cyclosporin A and FK506
58. 2+ requirements and sensitivity to cyclosporine A
59. Differential role of extra - And intracellular calcium in the release of EDRF and prostacyclin from cultured endothelial cells
60. Immunosuppressive therapy of autoimmune diseases
61. Novel mechanism for inhibition of human T cells by glucocorticoids: Glucocorticoids inhibit signal transduction through IL-2 receptor
62. Programmed T lymphocyte death: Cell activation- and steroid-induced pathways are mutually antagonistic
63. Cross-talk between the T cell antigen receptor and the glucocorticoid receptor regulates thymocyte development
64. Regulation of T lymphocyte apoptosis: Signals for the antagonism between activation- and glucocorticoid-induced death
65. A targeted glucocorticoid receptor antisense transgene increases thymocyte apoptosis and alters thymocyte development
66. To be or not to be: Mutually antagonistic death signals regulate thymocyte apoptosis
67. Regulation of T-cell death genes: Selective inhibition of FasL-but not Fas-mediated function
68. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
69. Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) is an inhibitor of autoimmune inflammation and cell cycle progression
70. Temperature-sensitive differential affinity of TRAIL for its receptors: DR5 is the highest affinity receptor
71. Tumor necrosis factor receptor family members in the immune system
72. A death factor: The other side of the coin
73. Human autoimmune lymphoproliferative syndrome, a defect in the apoptosis-inducing Fas receptor, a lesson from the mouse model
74. Expression of TRAIL receptors in human autoreactive and foreign antigen-specific T cells
75. Natural killer (NK) cell-mediated cytotoxicity: Differential use of TRAIL and Fas ligand by immature and mature primary human NK cells